|
1.
|
Wild S, Roglic G, Green A, Sicree R and
King H: Global prevalence of diabetes: estimates for the year 2000
and projection for 2030. Diabetes Care. 27:1047–1053.
2004.PubMed/NCBI
|
|
2.
|
Danaei G, Finucane MM, Lu Y, et al:
National, regional, and global trends in fasting plasma glucose and
diabetes prevalence since 1980: systematic analysis of health
examination surveys and epidemiological studies with 370
country-years and 2.7 million participants. Lancet. 378:31–40.
2011.
|
|
3.
|
International Diabetes Federation:
Diabetes Atlas. 3rd edition. International Diabetes Federation;
Brussels, Belgium: 2006
|
|
4.
|
Chen JCN, Malik V, Jia W, Kadowaki T,
Yajnik CS, Yoo KH and Hu FB: Diabetes in Asia: epidemiology, risk
factors, and pathophysiology. JAMA. 301:2129–2140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Tuomilehto J, Lindström J, Eriksson JG, et
al: Prevention of type 2 diabetes mellitus by changes in lifestyle
among subjects with impaired glucose tolerance. N Engl J Med.
344:1343–1350. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Lindström J, Ilanne-Parikka P, Peltonen M,
et al: Sustained reduction in the incidence of type 2 diabetes by
lifestyle intervention: Follow-up of the Finish Diabetes Prevention
Study. Lancet. 368:1673–1679. 2006.PubMed/NCBI
|
|
7.
|
Hanhineva K, Törrönen R, Bondia-Pons I,
Pekkinen J, Kolehmainen M, Mykkänen H and Poutanen K: Impact of
dietary polyphenols on carbohydrate metabolism. Int J Mol Sci.
11:1365–1402. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Aron PM and Kennedy JA: Flavan-3-ols:
nature, occurrence and biological activity. Mol Nutr Food Res.
52:79–104. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Yazaki Y: Acacia storyi: a
potential tannin-producing species. Australian Forestry. 60:24–28.
1997. View Article : Google Scholar
|
|
10.
|
Roux DG and Maihs EA: Condensed tannins. 3
Isolation and estimation of (−)-7:3′:4′:5′-tetrahydroxyflavan-3-ol,
(+)-catechin and (+)-gallocatechin from black-wattle-bark extract.
Biochem J. 74:44–49. 1960.
|
|
11.
|
Roux DG and Paulus E: Condensed tannins. 7
Isolation of (−)-7:3′:4′-trihydroxyflavan-3-ol [(−)-fisetinidol], a
naturally occurring catechin from black-wattle heartwood. Biochem
J. 78:120–123. 1961.
|
|
12.
|
Roux DG, Maihs EA and Paulus E: Condensed
tannins. 9 Distribution of flavonoid compounds in the heartwood and
barks of some interrelated wattles. Biochem J. 78:834–839.
1961.PubMed/NCBI
|
|
13.
|
Kusano R, Ogawa S, Matsuo Y, Tanaka T,
Yazaki Y and Kouno I: α-Amylase and lipase inhibitory activity and
structural characterization of acacia bark proanthocyanidins. J Nat
Prod. 74:119–128. 2011.
|
|
14.
|
Drewes SE and Roux DG: Condensed tannins.
15 Interrelationships of flavonoid components in wattle-bark
extract. Biochem J. 87:167–172. 1963.PubMed/NCBI
|
|
15.
|
Roux DG and Evelyn SR: Condensed tannins.
1 A study of complex leuco-anthocyanins present in condensed
tannins. Biochem J. 69:530–538. 1958.PubMed/NCBI
|
|
16.
|
Zheng G, Lin Y and Yazaki Y: Comparing
molecular size distribution of tannin extracts from Acacia
mearnsii bark from different countries. Holzforschung.
42:407–408. 1988.
|
|
17.
|
Ikarashi N, Toda T, Okaniwa T, Ito K,
Ochiai W and Sugiyama K: Anti-obesity and anti-diabetic effects of
acacia polyphenol in obese diabetic KKAy mice fed high-fat diet.
Evid Based Complement Alternat Med. 2011:9520312011. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Ikarashi N, Takeda R, Ito K, Ochiai W and
Sugiyama K: The inhibition of lipase and glucosidase activities by
acacia polyphenol. Evid Based Complement Alternat Med.
2011:2720752011. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Kataoka T, Ogawa S, Matsumae T, Yazaki Y
and Yamaguchi H: Safety of acacia polyphenol dietary supplement:
safety evaluation studies in healthy male adults. Pharmacometrics.
80:43–52. 2011.(In Japanese).
|
|
20.
|
Japan Diabetes Society: Guidelines for
Treatment of Diabetes 2002–2003. Bunkodo, Tokyo: 2002, (In
Japanese).
|
|
21.
|
American Diabetes Association: Diagnosis
and classification of diabetes mellitus. Diabetes Care. 27(Suppl
1): S5–S10. 2004. View Article : Google Scholar
|
|
22.
|
Katz A, Nambi SS, Mather K, Baron AD,
Follmann DA, Sullivan G and Quon MJ: Quantitative insulin
sensitivity check index: a simple, accurate method for assessing
insulin sensitivity in humans. J Clin Endocrinol Metab.
85:2402–2410. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Bonora E, Kiechl S, Willeit J, et al:
Prevalence of insulin resistance in metabolic disorders: the
Bruneck Study. Diabetes. 47:1643–1649. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Grassi D, Lippi C, Necozione S, Desideri G
and Ferri C: Short-term administration of dark chocolate is
followed by a significant increase in insulin sensitivity and a
decrease in blood pressure in healthy persons. Am J Clin Nutr.
81:611–614. 2005.PubMed/NCBI
|
|
25.
|
Grassi D, Desideri G, Necozione S, et al:
Blood pressure is reduced and insulin sensitivity increased in
glucose-intolerant, hypertensive subjects after 15 days of
consuming high-polyphenol dark chocolate. J Nutr. 138:1671–1676.
2008.
|
|
26.
|
The DECODE study group on behalf of the
European Diabetes Epidemiology Group: Glucose tolerance and
mortality comparison of WHO and American Diabetes Association
diagnostic criteria. Lancet. 354:617–662. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Osei K, Rhinesmith S, Gaillard T and
Schuster D: Impaired insulin sensitivity, insulin secretion, and
glucose effectiveness predict future development of impaired
glucose tolerance and type 2 diabetes in prediabetic African
Americans: implications for primary diabetes prevention. Diabetes
Care. 27:1439–1446. 2004. View Article : Google Scholar
|
|
28.
|
Thalhammer C, Balzuweit B, Busjahn A,
Walter C, Luft FC and Haller H: Endothelial cell dysfunction and
arterial wall hypertrophy are associated with disturbed
carbohydrate metabolism in patients at high risk for cardiovascular
disease. Arterioscler Thromb Vas Biol. 19:1173–1179. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
McNeeley MJ, Boyko EJ, Leonetti DL, Kahn
SE and Fujimoto WY: Comparison of a clinical model, the oral
glucose tolerance test, and fasting glucose for prediction of type
2 diabetes risk in Japanese Americans. Diabetes Care. 26:758–763.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
McLaughlin T, Abbasi F, Cheal K, Chu J,
Lamendola C and Reaven G: Use of metabolic markers to identify
overweight individuals who are insulin resistant. Am Intern Med.
139:802–809. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Kashiwabara H, Inaba M, Maruno Y, et al:
Insulin levels during fasting and the glucose tolerance test and
Homa’s index predict subsequent development of hypertension. J
Hypertens. 18:83–88. 2000.
|
